FAIR Health launches resource to support Alzheimer’s care planning and costs

Today, as part of a national initiative funded by The John A. Hartford Foundation (JAHF), the national, independent nonprofit FAIR Health launched a new shared decision-making tool for Alzheimer’s disease that features clinical information for self-care and drug therapy options, as well as related cost information.

Scoop: Led by former Trump official, Altesa BioSciences raises $35M for antivirals, recruits Moncef Slaoui to board

Altesa BioSciences has raised a $35 million Series A from undisclosed investors, according to an SEC filing from July. The company develops antiviral drugs for

September 30, 2023

Bristol wins U.S. approval for lung cancer drug targeting rare genetic mutation

The Food and Drug Administration on Wednesday approved a new treatment for people with non-small cell lung cancer that contains a rare genetic alteration called

November 16, 2023

Wesley Ramjeet to Join Lobe Sciences’ Board of Directors, Bringing Decades of Strategic Financial Expertise | Psychedelic Invest

VANCOUVER, British Columbia, June 03, 2024–(BUSINESS WIRE)–Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) (“Lobe” or the “Company”), a biopharmaceutical company focused on developing transformative medicines

June 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.